Journal Club

2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011

 

2014


Concordance between Molecular and Phenotypic Testing of Mycobacterium tuberculosis Complex Isolates for Resistance to Rifampin and Isoniazid in the United States

15.12.2014 (Daniel Goldenberger)
Yakrus MA et al.: Concordance between Molecular and Phenotypic Testing of Mycobacterium tuberculosis Complex Isolates for Resistance to Rifampin and Isoniazid in the United States J Clin Microbiol 52 1932-1937

Effects of Vaccination on Invasive Pneumococcal Disease in South Africa

08.12.2014 (Tamina Mosimann)
A.von Gottberg et al.: Effects of Vaccination on Invasive Pneumococcal Disease in South Africa NEJM 371 1980 13.11.2014

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomized, observer-masked, placebo-controlled trial

01.12.2014 (Maja Weisser)
Capeding MR: Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomized, observer-masked, placebo-controlled trial Lancet 384 1385-65 2014

Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial

24.11.2014 (Mario Kurz)
Louis Bernard: Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial The Lancet 1-8 2014

Recreational drug use, polydrug use, and sexual behaviour in HIV-diagnosed men who have sex with men in the UK:results from the cross-sectional ASTRA study

17.11.2014 (Marcel Stöckle)
Daskalopoulou M. et al.: Recreational drug use, polydrug use, and sexual behaviour in HIV-diagnosed men who have sex with men in the UK:
results from the cross-sectional ASTRA study
Lancet HIV 1 e22-e31 2014

β-Lactam Monotherapy vs β-Lactam–Macrolide Combination Treatment in Moderately Severe Community Acquired Pneumonia

10.11.2014 (Richard Kühl)
Garin N. et al.: β-Lactam Monotherapy vs β-Lactam–Macrolide Combination Treatment in Moderately Severe Community Acquired Pneumonia
JAMA Intern MedOnline: October 6, doi: 10.1001/jamainternmed.2014.4887 E1 bis E8 (online-Ausgabe)

Antibiotic treatment failure in four common infections in UK primary care 1991-2013: longitudinal analysis

27.10.2014 (Constantine Bloch-Infanger)
Craig J Currie: Antibiotic treatment failure in four common infections in UK primary care 1991-2013: longitudinal analysis BMJ 349:g5493 Keine Seitenangaben 2014

Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug users

20.10.14 (Luigia Elzi)
Barrella Harboe Z. et al.: Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug users Clin Infect Dis 59 1168-76 2014

Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis

13.10.2014 (Veronika Bättig)
Gillespie SH et al.: Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis NEJM [Epub ahead of print] 2014 Sep 7

A Systematic Review: Can One Prescribe Carbapenems to Patients With IgE-Mediated Allergy to Penicillins or Cephalosporins?

06.10.2014 (Benedikt Wiggli)
Kula B. et al.: A Systematic Review: Can One Prescribe Carbapenems to Patients With IgE-Mediated Allergy to Penicillins or Cephalosporins? CID 59(8) 1113–22 2014

Temporal Response of the Human Virome to Immunosuppression and Antiviral Therapy

29.09.2014 (Adrian Egli)
De Vlaminck I. et al.: Temporal Response of the Human Virome to Immunosuppression and Antiviral Therapy Cell 155 1178-1187 2013

Effectiveness of Clindamycin and Intravenous Immunoglobulin, and Risk of Disease in Contacts, in Invasive Group A Streptococcal Infections

15.09.14 (Florian Banderet-Uglioni)
Carapetis JR et al.: Effectiveness of Clindamycin and Intravenous Immunoglobulin, and Risk of Disease in Contacts, in Invasive Group A Streptococcal Infections CID 59 358-365 2014
http://www.ncbi.nlm.nih.gov/pubmed/25344540

Wastewater Treatment Plants Release Large Amounts of Extended-Spectrum ß-lactamse-producing Escherichia coli into the Environment

08.09.2014 (Esther Künzli)
Bréchet C et al.: Wastewater Treatment Plants Release Large Amounts of Extended-Spectrum ß-lactamse-producing Escherichia coli into the Environment CID 58 1658-1665 2014

Ritonavir-boosted darunavir combined with raltegravir or tenofovir—emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial

25.08.2014 (Jan Sidler)
Raffi F. et al.: Ritonavir-boosted darunavir combined with raltegravir or tenofovir—emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial Lancet NA (Epub ahead of print) NA (Epub ahead of print) 2014

Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial

18.08.2014 (Tamina Mosimann)
Alice C Eziefula et al.: Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial Lancet Infect Dis 14 130-139 2014

Impact of GeneXpert MTB/RIF on Triage of Respiratory Isolation Rooms for Inpatients with Presumed TB: A Hypothetical Trial.

11.08.2014 (Michael Osthoff)
Chaisson LH: Impact of GeneXpert MTB/RIF on Triage of Respiratory Isolation Rooms for Inpatients with Presumed TB: A Hypothetical Trial. Clin Infect Dis Aug 4. pii: ciu620. [Epub ahead of print] N/a 2014

Fidaxomicin Versus Vancomycin for
Clostridium difficile Infection: Meta-analysis
of Pivotal Randomized Controlled Trials

04.08.2014 (Sarah Tschudin Sutter)
Crook D. W. et al.: Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials Clin Infect Dis 55 93-103 2012

ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV

28.07.2014 (Adrian Schibli)
P. Ferenci et al.: ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV NEJM 370 (21) 1983-1992 2014

Independent contribution of bronchioalveolar lavage and serum galactomannan in the diagnosis of invasive pulmonary aspergillosis

21.07.2014 (Nina Khanna)
Fisher CE et al.: Independent contribution of bronchioalveolar lavage and serum galactomannan in the diagnosis of invasive pulmonary aspergillosis Transpl Infect Dis 16 505-510 2014

Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis

14.07.2014 (Elisabeth Wehrle)
Boulware DR et al.: Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis NEJM 370;26 2487-2498 2014
www.ncbi.nlm.nih.gov/pubmed/2522993

Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial

07.07.2014 (Manuel Battegay)
Grinsztejn B et al.: Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial Lancet Infect Dis 14 281–90 2014

Dalbavancin und Oritavancin, zwei neue Glycopeptid-Antibiotika zur Therapie von Haut und Weichteil-Infektionen

30.06.2014 (Florian Banderet-Uglioni)
1. Corey G. et al.: Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections
2. Boucher A et al.: Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection NEJM 370 1. 2180-2190 1. 2169-2176 2014

Systematic PCR Detection on Culture-negative Osteoarticular Infections

16.6.2014 (Daniel Goldenberger)
Levy PY et al.: Systematic PCR Detection on Culture-negative Osteoarticular Infections Am J Med 1143 E25-e33 2013

Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation

02.06.2014 (Mario Kurz)
Rox F. Chemaly: Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation N Engl J Med 370 1781-1789 2014

Ribavirin for Chronic Hepatitis E Virus Infection in Transplant Recipients

26.05.2014 (Bernardini Claudia)
Kamar N. et al.: Ribavirin for Chronic Hepatitis E Virus Infection in Transplant Recipients NEJM 370: 1111-20 2014

DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current β-Lactam Antibiotic Doses Sufficient for Critically Ill Patients?

19.05.2014 (Aurélien Martinez)
Roberts J. et al.: DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current β-Lactam Antibiotic Doses Sufficient for Critically Ill Patients? CID 58 (8) 1072-83 2014

Parainfluenza Virus Lower Respiratory Tract Disease After Hematopoietic Cell Transplant: Viral Detection in the Lung Predicts Outcome

05.5.2014 (Barbara Jakopp)
Sachiko et al.: Parainfluenza Virus Lower Respiratory Tract Disease After Hematopoietic Cell Transplant: Viral Detection in the Lung Predicts Outcome CID 58 Online Version; noch keine Seitenzahlen 2014

Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study

14.04.2014 (Danielle Vuichard)
Hayward AC. et al.: Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study Lancet Respir Med Published Online March 17, 2014 http://dx.doi.org/10.1016/ S2213-2600(14)70034-7 1-11 2014

Infectious Diseases Speciality Intervention Is Associated With Decreased Mortality and Lower Health Costs

07.04.2014 (Adrian Schibli)
Schmitt S. et al.: Infectious Diseases Speciality Intervention Is Associated With Decreased Mortality and Lower Health Costs CID 58 22-28 2014

Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection

24.3.2014 (Egli Adrian)
Liehl Peter et al: Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection Nature Medicine 20 47-52 2014

Impact of Rapid Organism Identification via Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Combined with Antimicrobial Stewardship Team Intervention in Adult Patients With Bacteremia and Candidemia

17.03.2014 (Michael Osthoff)
Huang AM et al.: Impact of Rapid Organism Identification via Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Combined with Antimicrobial Stewardship Team Intervention in Adult Patients With Bacteremia and Candidemia Clin Infect Dis Nov;57(9) 1237-45 2013

The cascade of HIV care in British Columbia, Canada, 1996-2011: a population-based retrospective cohort study

03.03.2014 (Veronika Bättig)
Nosyk B. et al.: The cascade of HIV care in British Columbia, Canada, 1996-2011: a population-based retrospective cohort study Lancet Infect Dis 14 40-49 2014

Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial

24.02.2014 (Esther Künzli)
Fry A. M. et al.: Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial Lancet Infect Dis 14 109-118 2014

Effect of Adequate Single-Drug vs Combination Antimicrobial Therapy on Mortality in Pseudomonas aeruginosa Bloodstream Infections: A Post Hoc Analysis of a Prospective Cohort

17.02.2014 (Aurélien Martinez)
Peña C. et al: Effect of Adequate Single-Drug vs Combination Antimicrobial Therapy on Mortality in Pseudomonas aeruginosa Bloodstream Infections: A Post Hoc Analysis of a Prospective Cohort Clin Infect Dis Jul;57(2): 208-16 2013

Predictors of virologic response in persons who start antiretroviral therapy during recent HIV infection

10.02. 2014 (Marilia Santini de Oliveira)
Karris MY et al.: Predictors of virologic response in persons who start antiretroviral therapy during recent HIV infection AIDS 3 Epub ahead of print 2014

A Trial of Mass Isoniazid Preventive Therapie for Tuberculosis Control

03.02.2014 (Florian Banderet)
Churchyard G. et al.: A Trial of Mass Isoniazid Preventive Therapie for Tuberculosis Control NEJM 370;4 301-310 2014

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

27.01.2014 (Mario Kurz)
Mark S. Sulkowski: Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection N Engl J Med 307;3 211-221 2014

Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial

20.01.14 (Sarah Tschudin Sutter)
Derde LP et al.: Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial Lancet Infect Dis 14 31-9 2013


Whole-genome sequencing shows that patient-to-patient transmission rarely accounts for acquisition of Staphylococcus aureus on an intensive care unit

13.01.2014 (Botond Lakatos)
Price JR et al.: Whole-genome sequencing shows that patient-to-patient transmission rarely accounts for acquisition of Staphylococcus aureus on an intensive care unit CID December 12. Epub ahead of print 2013

Inactivation of Hepatitis C Virus Infectivity by Human Breast Milk

06.01.14 (Barbara Jakopp)
Stephanie Pfaender: Inactivation of Hepatitis C Virus Infectivity by Human Breast Milk JID 208 1943-52 2013